−4400KRW
−24.19 BKRW
160.35 BKRW
3.34 M
About CKD BIO
Sector
CEO
Jeong-Jin Lee
Headquarters
Seoul
Website
Employees (FY)
500
Founded
2001
ISIN
KR7063160006
FIGI
BBG000LDWB16
CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients. Its products include potassium clavulanate, cyclosporine, tacrolimus, demeclocycline hydrochloride, rifampicin, rifampicin SV sodium, teicoplanin, vancomycin HCL, fumagillin, diquafosol sodium, everolimus, daptomycin, tenofovir disoproxil aspartate, and acarbose. The company was founded on November 12, 2001 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 063160 is 23450 KRW — it has decreased by 1.68% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CKD BIO stocks are traded under the ticker 063160.
063160 stock is 3.47% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is CKD BIO there?
CKD BIO revenue for the last quarter amounts to 34.90 B KRW despite the estimated figure of 35.65 B KRW. In the next quarter revenue is expected to reach 35.55 B KRW.
Yes, you can track CKD BIO financials in yearly and quarterly reports right on TradingView.
063160 stock has risen by 2.18% compared to the previous week, the month change is a 7.13% fall, over the last year CKD BIO has showed a 13.79% decrease.
063160 net income for the last quarter is −8.14 B KRW, while the quarter before that showed −6.40 B KRW of net income which accounts for −27.18% change. Track more CKD BIO financial stats to get the full picture.
Today CKD BIO has the market capitalization of 130.84 B, it has decreased by 2.74% over the last week.
Like other stocks, 063160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CKD BIO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 500.00 employees. See our rating of the largest employees — is CKD BIO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CKD BIO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CKD BIO stock shows the neutral signal. See more of CKD BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CKD BIO EBITDA is −2.61 B KRW, and current EBITDA margin is −1.63%. See more stats in CKD BIO financial statements.